Sri Lanka cuts interest rates after debt restructure-
By AFP COLOMBO: Cash-strapped Sri Lanka cut interest rates on Thursday, a week after announcing a major debt restructuring in […]
rates
Gorakhpur cumin seeds rates are high at this time know the market price – News18 हिंदी
रजत भट्ट/गोरखपुर: गोरखपुर में इन दिनों महंगाई अपने चरम पर है. खाने-पीने से लेकर हर सामान महंगा हो चुका है.
GST Day 2023 Goods and Services Tax done justice to consumers by bringing rates down FM Nirmala Sitharaman latest update
Image Source : PTI Union Minister of Finance and Corporate Affairs Nirmala Sitharaman speaks during celebration of 6th Goods and
Centre hikes interest rates on some small saving schemes for July-September quarter
Image Source : FILE Centre hikes interest rates on small saving schemes The Central government on Friday raised interest rates
No change in TCS rates up to Rs 7 lakh per annum: Finance Ministry
Image Source : INDIA TV Breaking News The Finance Ministry on Wednesday said that there will not be any change
Noida farmers refuse to part with land at govt rates around new airport-
By Express News Service NOIDA: The Yamuna Expressway Industrial Development Authority (YEIDA) on Monday admitted facing difficulty in acquiring land from
Ashes 2023 Australia and England penalised for slow over rates in first Test | Ashes 2023: ICC ने लिया तगड़ा एक्शन, इन दो टीमों पर ठोका भारी जुर्माना; ये रही वजह
Ashes 2023 ENG vs AUS: इंग्लैंड और ऑस्ट्रेलिया के के बीच जारी द एशेज (Ashes 2023) का पहला टेस्ट मैच
Punjab government increases petrol and diesel rates, second hike in four months-
By Express News Service CHANDIGARH: The AAP-led Punjab Government has increased petrol price by 92 paise per litre and diesel
RBI decides to hold rates again, but in no hurry to declare victory in war on inflation-
Express News Service HYDERABAD: On Thursday, the central bank’s Monetary Policy Committee (MPC) unanimously agreed to extend the pause on
Two new cancer pills show ‘unprecedented’ results in boosting survival rates and preventing recurrence
Potentially “practice-changing” results from two new cancer drug studies were introduced at the American Society of Clinical Oncology (ASCO)’s annual